– ABOUT OMIX3 and PX4 Platform The OMIX3 platform represents a transformative step forward in Australia’s research infrastructure, delivering high-capacity, multi-omics capabilities to advance clinical research and precision medicine. With $15.83M in funding...
– ABOUT Omico’s PrOSPeCT Program Omico is transforming cancer care in Australia by accelerating access to precision oncology. As a national, independent, not-for-profit organisation, Omico brings together Australia’s leading cancer institutes, researchers,...
– ABOUT Melanoma Population Screening Melanoma is the third most common cancer in Australia and the leading cause of cancer-related deaths among young Australians. While population-wide screening is economically unfeasible, targeted screening for high-risk...
– ABOUT Australian Genomics Australian Genomics is a national initiative driving the integration of genomics into healthcare to improve outcomes for all Australians. Established in 2016 with a $25 million National Health and Medical Research Council (NHMRC)...
– ABOUT CAD FRONTIERS CAD Frontiers is a transformative initiative addressing coronary artery disease (CAD), the leading cause of premature death globally. With an Australian-led, international team, CAD Frontiers combines multidisciplinary expertise,...
